Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Atsuo Nakagawa, MD
JCP
Original Research
CBT for Pharmacotherapy-Resistant Depression
February 28, 2017
Read a randomized control trial examining whether adding cognitive-behavioral therapy (CBT) for Pharmacotherapy-Resistant Depression improves outcomes.
Atsuo Nakagawa
,
Dai Mitsuda
,
Mitsuhiro Sado
, et al
JCP
Original Research
Does Randomized Evidence Support Sertraline as First-Line Antidepressant for Adults With Acute Major Depression? A Systematic Review and Meta-Analysis
November 30, 2008
Andrea Cipriani
,
Toshiaki A. Furukawa
,
John R. Geddes
, et al
JCP
Original Research
Mirtazapine Versus Other Antidepressants in the Acute-Phase Treatment of Adults With Major Depression: Systematic Review and Meta-Analysis
September 30, 2008
Norio Watanabe
,
Ichiro M. Omori
,
Atsuo Nakagawa
, et al
JCP
Original Research
Association of Suicide and Antidepressant Prescription Rates in Japan, 1999-2003
June 15, 2007
Atsuo Nakagawa
,
Michael F. Grunebaum
,
Steven P. Ellis
, et al
